The size of the Korean cell culture market is expected to reach USD 216.3 million in 2019, reaching USD 66.4 million by 2027, and is expected to grow at a CAGR of 13% from 2021 to 2027.
Factors driving the growth of the cell culture market include cancer prevalence, increased adoption of cell culture technology, and increased funding for research in Korea. For example, according to a report published by the National Cancer Center, cancer is the most common cause of death in Korea and accounts for one in three domestic deaths. The number of domestic cancer cases in 2016 was 231,236, which increased to 232,255 in 2017. Each major company offers cell culture products that are continuously used in cancer research.
A full report of South Korea Cell Culture Market available at https://www.orionmarketreports.com/south-korea-cell-culture-market/55823/
South Korea Cell Culture Market Segmentation
By Product
• Consumables
• Instruments
By Application
• Stem Cell Technology
• Cancer Research
• Drug Screening and Development
• Tissue Engineering & Regenerative Medicine
• Others
By End User
• Research Institutes
• Pharmaceutical & Biotechnology Companies
• Others
List of key players profiled in the report
• Avantor, Inc. (VWR International, LLC)
• Bio-Rad Laboratories Inc.
• Corning Incorporated
• Danaher Corporation (Cytiva)
• FUJIFILM Holdings Corporation (FUJIFILM Irvine Scientific, Inc.)
• Merck KGaA
• Miltenyi Biotec B.V. & Co. KG
• Sartorius AG
• STEMCELL Technologies Inc.
• Thermo Fisher Scientific Inc.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
